GUILFORD, Conn.--(BUSINESS WIRE)--Quantum-Si, a Connecticut-based start-up, today introduced the world’s first next-generation protein sequencing platform at Cowen Healthcare 2020. The Quantum-Si ...

In ancient Greek lore, Proteus, son of Poseidon, held the allure of wisdom and foresight, yet could only be approached by those with the means to capture him. Much like this mythical figure, proteins, ...

As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma, biotech, and industrial biology. Ainnocence is expanding partnerships, ...

Researchers at Colorado State University have determined how to use artificial intelligence to modify antibodies so they act ...

Barcoding technologies that take advantage of the high information content that can be encoded in oligonucleotide sequences have enabled a wide array of applications in biotechnology, particularly ...

Protein sequencing presents different challenges than nucleic acid sequencing, meaning that proteomics has yet to benefit as much as genomics from the next-generation sequencing revolution. However, ...

On Wednesday, Quantum-Si Incorporated (NASDAQ:QSI) stock traded over 100% higher after the protein sequencing company announced a collaboration with NVIDIA Corporation (NASDAQ:NVDA) to develop its new ...

Proteins, through their diversity, are vital determinants of phenotype and function. Humans possess potentially millions of protein variants (proteoforms), derived through mechanisms including ...

Quantum-Si aims to revolutionize protein sequencing but faces significant technological and competitive challenges. Commercial reception to Quantum-Si's solutions has been lukewarm so far, suggesting ...